文献速递创伤骨科脊柱外科关节外科

在骨科就诊时讨论患者报告结局指标是否增加疼痛自我效能?一项前瞻性序贯比较系列研究

Does Discussing Patient-reported Outcome Measures Increase Pain Self-efficacy at an Orthopaedic Visit? A Prospective, Sequential, Comparative Series.
PubMed 文献 · Clin Orthop Relat Res · 2024-11-22

该前瞻性序贯比较系列在2023年2月至10月于单个大型三级转诊中心的多专科骨科门诊完成,前64例接受标准诊疗,后64例在初诊时与骨科医生讨论PROMIS PF-SF10a评分。两组PSEQ评分变化无差异(标准诊疗组4±10 vs PROMs组3±7,均差1[95%CI -2.0至4.0];p=0.29)。讨论PROMs结果并未在一次就诊中增加疼痛自我效能。

要点

  • 讨论PROMIS PF-SF10a评分与标准诊疗相比,PSEQ评分变化无差异(均差1[95%CI -2.0至4.0];p=0.29)。
  • 标准诊疗组56%(36/64)疼痛自我效能增加,其中22%(14/64)有临床重要改善;PROMs组59%(38/64)增加,其中19%(12/64)有临床重要改善。
  • 两组PSEQ变化与BRS或OPTION-5评分均无相关性。

核心结论

  • 在就诊时讨论PROMs结果(PROMIS PF-SF10a)并未在一次就诊中增加疼痛自我效能。
  • 因此,外科医生无需为了影响患者疼痛自我效能而讨论疼痛自我效能PROM评分。
  • PROMs仍是评估患者结局的有价值工具,进一步工作可评估收集PROMs本身是否增加疼痛自我效能,或纵向讨论PROMs是否改变疼痛自我效能。

研究设计与样本

  • 前瞻性序贯比较系列,于2023年2月至10月在单个大型三级转诊中心的多专科骨科门诊完成。
  • 骨科亚专科包括全关节置换、脊柱、手、运动医学和创伤。
  • 前64例患者接受标准诊疗,后64例在初诊时与骨科医生讨论其PROMs。
  • 就诊前收集PSEQ、BRS和PROMIS PF-SF10a评分及人口学特征。
  • 标准诊疗组未与患者讨论PROMIS PF-SF10a评分;PROMs组医生使用脚本讨论PROMIS PF-SF10a评分,允许但不要求对所有患者进行额外讨论。

主要发现

  • PROMs组与标准诊疗组就诊前后PSEQ评分变化无差异(标准诊疗组平均±SD变化4±10 vs PROMs组3±7,均差1[95%CI -2.0至4.0];p=0.29)。
  • 标准诊疗组56%(36/64)患者疼痛自我效能增加,其中22%(14/64)有临床重要改善;PROMs组59%(38/64)增加,其中19%(12/64)有临床重要改善。
  • 标准诊疗组PSEQ变化与心理韧性无相关性(BRS评分r=-0.13[95%CI -0.36至0.12];p=0.30),与患者参与决策无相关性(OPTION-5 r=0.003[95%CI -0.24至0.25];p=0.98)。
  • PROMs组PSEQ变化与心理韧性无相关性(BRS评分r=-0.10[95%CI -0.33至0.16];p=0.45),与患者参与决策无相关性(OPTION-5 r=-0.02[95%CI -0.26至0.23];p=0.88)。

关键数值与推荐

  • PSEQ最小临床重要差异定义为8.5分。
  • 主要结局为PSEQ评分变化。
  • 次要结局为PSEQ变化与BRS或OPTION-5的相关性。

临床怎么用

  • 作者认为,外科医生无需为了影响患者疼痛自我效能而讨论疼痛自我效能PROM评分。
  • 作者指出PROMs仍是评估患者结局的有价值工具。
  • 作者提出进一步工作可评估收集PROMs本身是否增加疼痛自我效能,或纵向讨论PROMs是否改变疼痛自我效能。

局限性

  • 作者指出进一步工作可评估收集PROMs本身是否增加疼痛自我效能,或纵向讨论PROMs是否改变疼痛自我效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pain self-efficacy, or the ability to carry out desired activities in the presence of pain, can affect a patient's ability to function before and after orthopaedic surgery. Previous studies suggest that shared decision-making practices such as discussing patient-reported outcome measures (PROMs) can activate patients and improve their pain self-efficacy. However, the ability of PROMs to influence pain self-efficacy in patients who have undergone orthopaedic surgery has yet to be investigated. QUESTIONS/PURPOSES: (1) Is immediately discussing the results of a PROM associated with an increase pain self-efficacy in new patients presenting to the orthopaedic surgery clinic? (2) Is there a correlation between patient resilience or patient involvement in decision-making in changes in pain self-efficacy? METHODS: This was a prospective, sequential, comparative series completed between February to October 2023 at a single large tertiary referral center at a multispecialty orthopaedic clinic. Orthopaedic subspecialties included total joint arthroplasty, spine, hand, sports, and trauma. The first 64 patients underwent standard care, and the following 64 had a conversation with their orthopaedic surgeon about their PROMs during the initial intake visit. We collected scores from the Pain Self-Efficacy Questionnaire (PSEQ), Brief Resilience Scale (BRS), and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function form (PF-SF10a) and data on demographic characteristics before the visit. The PSEQ is a validated PROM used to measure pain self-efficacy, while the BRS measures the ability of patients to recover from stress, and the PROMIS PF-SF10a is used to assess overall physical function. PROMs have been utilized frequently for their ability to report the real-time physical and psychological well-being of patients. In the standard care group, the PROMIS PF-SF10a score was not discussed with the patient. In the PROMs group, the physician discussed the PROMIS PF-SF10a score using a script that gave context to the patient's score. Additional conversation about the patient's score was permitted but not required for all patients. Scores from the Observing Patient Involvement in Decision Making (OPTION-5) instrument were recorded during the visit as a measure of patient involvement in clinical decision-making. After the visit, both groups completed the PSEQ. The primary outcome was change in the PSEQ. Change in pain self-efficacy was recorded as greater or less than the minimum clinically important difference, previously defined at 8.5 points for the PSEQ [ 10 ]. The secondary outcomes were correlation between PSEQ change and the BRS or OPTION-5. RESULTS: Between the PROMs and standard care groups, there was no difference in the change in PSEQ scores from before the visit to after (mean ± SD change in control 4 ± 10 versus change in PROMs group 3 ± 7, mean difference 1 [95% confidence interval (CI) -2.0 to 4.0]; p = 0.29). Fifty-six percent (36 of 64) of patients in the standard care group demonstrated an increase in pain self-efficacy (of whom 22% [14 of 64] had clinically important improvements), and 59% (38 of 64) of patients in the PROMs group demonstrated an increase in pain self-efficacy (of whom 19% [12 of 64] had clinically important improvements). In the control group, there was no correlation between the change in PSEQ score and resiliency (BRS score r = -0.13 [95% CI -0.36 to 0.12]; p = 0.30) or patient involvement in decision-making (OPTION-5 r = 0.003 [95% CI -0.24 to 0.25]; p = 0.98). Similarly, in the PROMs group, there was no correlation between the change in PSEQ score and resiliency (BRS score r = -0.10 [95% CI -0.33 to 0.16]; p = 0.45) or patient involvement in decision-making (OPTION-5 r = -0.02 [95% CI -0.26 to 0.23]; p = 0.88). CONCLUSION: Discussing PROMs results (PROMIS PF-SF10a) at the point of care did not increase pain self-efficacy during one visit. Therefore, surgeons do not need to discuss pain self-efficacy PROM scores in order to influence patient pain self-efficacy. While PROMs remain valuable tools for assessing patient outcomes, further work may assess whether the collection of PROMs itself may increase pain self-efficacy or whether longitudinal discussion of PROMs with patients changes pain self-efficacy. LEVEL OF EVIDENCE: Level II, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Schultz EA, Gomez GI, Gardner MJ, et al. Does Discussing Patient-reported Outcome Measures Increase Pain Self-efficacy at an Orthopaedic Visit? A Prospective, Sequential, Comparative Series. Clin Orthop Relat Res. 2024. PMID: 39589313. doi:10.1097/CORR.0000000000003325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。